http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010028216-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e25f6052d6dae01fa5d697d5a60c28e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca33641f0b9d97bec5d105ab2b8dfa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38229c14bb293e1236e0020abd1f5f12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a182fc7c102cfba72b2016ef76b985af
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-547
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-12
filingDate 2009-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_490750510e8775d8e1c185e04ebcdd85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5e69f1850785ba36c277cea65658034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d876f2c1f4093f62015ec176e8cf6f
publicationDate 2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010028216-A8
titleOfInvention Porphyrazine optical and dual optical/mr contrast and therapeutic agents
abstract Porphyrazines capable of localizing in a tumor of a mammal are disclosed. The porphyrazines are used in methods of imaging a tumor and in methods of treating tumors, either alone or in combination with a chemotherapeutic agent and/or radiation.
priorityDate 2008-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18965963

Total number of triples: 34.